Immobazyme, a pioneering biotechnology company, is thrilled to announce the successful closure of its latest funding round, bringing its total investment to R24.5 million.
This significant investment will fuel the company’s expansion plans, enabling it to double the size of its facility and significantly scale up production capabilities.
Key contributors to this achievement include:
- The University Technology Fund (UTF): Daniel S., Wayne Stocks, and the entire UTF team have been instrumental in supporting Immobazyme’s journey.
- Innovus Technology Transfer Office at Stellenbosch University (USE): The team at USE has dedicated countless hours to bring this deal to fruition.
- Immobazyme’s Founders: Dominic Nicholas, Ethan Hunter, and Nick Enslin have provided unwavering leadership and vision.
Immobazyme creates cost-effective, animal-origin-free growth factors for cellular agriculture.
Immobayzme’s recombinant growth factors are produced using their modular protein expression system.
This system enables a scaleable, efficient and versatile solution that addresses increased demand and unlocks affordability in the different sectors they serve.
